VICO — Vicore Pharma Holding AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK1.93bn
- SEK1.45bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -94 | -150 | -295 | -291 | -322 |
Depreciation | |||||
Non-Cash Items | 2.01 | 6.2 | 2.1 | 10.6 | 62 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3.66 | 23.4 | 27.5 | -19.8 | 6.54 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -87 | -120 | -265 | -300 | -250 |
Capital Expenditures | -0.147 | -3 | 0 | -3 | 0 |
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -77 | 7 | -7 | 77 | -144 |
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -77.1 | 4 | -7 | 74 | -144 |
Financing Cash Flow Items | -7.58 | -10.4 | -17.6 | -12.7 | -29.5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 127 | 177 | 318 | 187 | 471 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -37.1 | 61 | 45.6 | -37.4 | 76.8 |